Madeleine R Heldman1, Kexin Guo2, Brett Nelson3, Tenzin Babu4, Michael G Ison2,5. 1. Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA. 2. Comprehensive Transplant Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 3. Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA. 4. University of Southern California, Los Angeles, CA, USA. 5. Divisions of Infectious Diseases and Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Abstract
BACKGROUND: Infections caused by multidrug-resistant gram-negative bacilli (GNB) cause significant morbidity and mortality in solid organ transplant (SOT) recipients. METHODS: We retrospectively collected data from all SOT recipients at a single center from 1 January 2007 to 15 April 2017 treated for infections caused by multi-drug-resistant GNB. This study examined the effects of specific antibiotics on nephrotoxicity, neurotoxicity, 30-day mortality, and length of stay in the hospital and intensive care unit. RESULTS: A total of 225 infections were identified among 143 patients. Carbapenem-sensitive organisms were present in 112 (49.8%) infections and were associated with decreased 30-day mortality (OR 0.35, 95% CI 0.16-0.75). Neurotoxicity was associated with polymyxin use with an 8% increase in odds of neurotoxicity per day of exposure (P=.03). There was no relationship between nephrotoxicity and any individual antibiotic class. Increased hospital length-of-stay occurred among patients exposed to aminoglycosides (β-statistic = 0.48 (0.23); P = .04), while there was no relationship between antibiotic class and intensive care unit (ICU) length-of-stay. Mortality at 30 days occurred in 37 infections (16%). Carbapenem exposure was associated with decreased 30-day mortality (OR 0.93; 95% CI 0.90-0.98; P = .02). No other antibiotic class had a significant impact on 30-day mortality. CONCLUSIONS: Carbapenems appear to be a safe and effective treatment for solid-organ transplant recipients with infections caused by carbapenem-sensitive multidrug-resistant GNB; treatment of carbapenem-resistant gram-negatives remains challenging.
BACKGROUND: Infections caused by multidrug-resistant gram-negative bacilli (GNB) cause significant morbidity and mortality in solid organ transplant (SOT) recipients. METHODS: We retrospectively collected data from all SOT recipients at a single center from 1 January 2007 to 15 April 2017 treated for infections caused by multi-drug-resistant GNB. This study examined the effects of specific antibiotics on nephrotoxicity, neurotoxicity, 30-day mortality, and length of stay in the hospital and intensive care unit. RESULTS: A total of 225 infections were identified among 143 patients. Carbapenem-sensitive organisms were present in 112 (49.8%) infections and were associated with decreased 30-day mortality (OR 0.35, 95% CI 0.16-0.75). Neurotoxicity was associated with polymyxin use with an 8% increase in odds of neurotoxicity per day of exposure (P=.03). There was no relationship between nephrotoxicity and any individual antibiotic class. Increased hospital length-of-stay occurred among patients exposed to aminoglycosides (β-statistic = 0.48 (0.23); P = .04), while there was no relationship between antibiotic class and intensive care unit (ICU) length-of-stay. Mortality at 30 days occurred in 37 infections (16%). Carbapenem exposure was associated with decreased 30-day mortality (OR 0.93; 95% CI 0.90-0.98; P = .02). No other antibiotic class had a significant impact on 30-day mortality. CONCLUSIONS: Carbapenems appear to be a safe and effective treatment for solid-organ transplant recipients with infections caused by carbapenem-sensitive multidrug-resistant GNB; treatment of carbapenem-resistant gram-negatives remains challenging.
Authors: L F A Camargo; A R Marra; A C C Pignatari; T Sukiennik; P P P Behar; E A S Medeiros; J Ribeiro; E Girão; L Correa; C Guerra; C Brites; C A P Pereira; I Carneiro; M Reis; M A Souza; C U Barata; M B Edmond Journal: Transpl Infect Dis Date: 2015-03-02 Impact factor: 2.228
Authors: Philipp P Kohler; Cheryl Volling; Karen Green; Elizabeth M Uleryk; Prakesh S Shah; Allison McGeer Journal: Infect Control Hosp Epidemiol Date: 2017-09-27 Impact factor: 3.254
Authors: J M Aguado; J T Silva; M Fernández-Ruiz; E Cordero; J Fortún; C Gudiol; L Martínez-Martínez; E Vidal; L Almenar; B Almirante; R Cantón; J Carratalá; J J Caston; E Cercenado; C Cervera; J M Cisneros; M G Crespo-Leiro; V Cuervas-Mons; J Elizalde-Fernández; M C Fariñas; J Gavaldà; M J Goyanes; B Gutiérrez-Gutiérrez; D Hernández; O Len; R López-Andujar; F López-Medrano; P Martín-Dávila; M Montejo; A Moreno; A Oliver; A Pascual; E Pérez-Nadales; A Román-Broto; R San-Juan; D Serón; A Solé-Jover; M Valerio; P Muñoz; J Torre-Cisneros Journal: Transplant Rev (Orlando) Date: 2017-07-26 Impact factor: 3.943
Authors: S H Shi; H S Kong; J Xu; W J Zhang; C K Jia; W L Wang; Y Shen; M Zhang; S S Zheng Journal: Transpl Infect Dis Date: 2009-07-22 Impact factor: 2.228